Latest Articles
Prediction of recurrence risk in endometrial cancer with multimodal deep learning - Nature.com
Prediction of recurrence risk in endometrial cancer with multimodal deep learning Nature.com
Published: May 24, 2024, 7 a.m.
Exploring the protective effect of contraceptive methods against gynaecological cancer - International Federation of Gynecology and Obstetrics
Exploring the protective effect of contraceptive methods against gynaecological cancer International Federation of Gynecology and Obstetrics
Published: May 24, 2024, 7 a.m.
Endometriosis CARE Act Reintroduced at the Capitol, EndoFound Is There to Support the Cause - Endometriosis Foundation of America - The Blossom
Endometriosis CARE Act Reintroduced at the Capitol, EndoFound Is There to Support the Cause Endometriosis Foundation of America - The Blossom
Published: May 23, 2024, 7 a.m.
Mayo scientists explore swabs for early endometrial, ovarian cancer detection - Mayo Clinic
Mayo scientists explore swabs for early endometrial, ovarian cancer detection Mayo Clinic
Published: May 23, 2024, 7 a.m.
EndoFound to Be Present in Washington, D.C., on Thursday as Endometriosis CARE Act Is Reintroduced - Endometriosis Foundation of America - The Blossom
EndoFound to Be Present in Washington, D.C., on Thursday as Endometriosis CARE Act Is Reintroduced Endometriosis Foundation of America - The Blossom
Published: May 22, 2024, 7 a.m.
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway - Nature.com
IGF2BP2-modified circular RNA circCHD7 promotes endometrial cancer progression via stabilizing PDGFRB and activating JAK/STAT signaling pathway Nature.com
Published: May 22, 2024, 7 a.m.
Dr Bou Farhat on a Retrospective Study of NGS vs IHC Sensitivity for dMMR CRC and Endometrial Cancer - OncLive
Dr Bou Farhat on a Retrospective Study of NGS vs IHC Sensitivity for dMMR CRC and Endometrial Cancer OncLive
Published: May 21, 2024, 7 a.m.
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous Ovarian Cancer - GlobeNewswire
eFFECTOR Therapeutics to Collaborate with the Dana-Farber Cancer Institute on an Investigator-Sponsored Phase 2 Clinical Trial Evaluating Zotatifin as Combination Treatment in ER+ Endometrial Cancer and in Low Grade Serous …
Published: May 20, 2024, 7 a.m.
‘Oh my gosh’: Project host stunned - news.com.au
‘Oh my gosh’: Project host stunned news.com.au
Published: May 20, 2024, 7 a.m.
Women are seeking reproductive health information later in life, with experts saying it should start earlier - ABC News
Women are seeking reproductive health information later in life, with experts saying it should start earlier ABC News
Published: May 19, 2024, 7 a.m.
Link copied to clipboard!